PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
17-Jul-2024 Artificial intelligence speeds up heart scans, saving doctors’ time, and could lead to better treatment for heart conditions University of East Anglia
17-Jul-2024 JASCO and Bioz Join Forces for a Second Year to Empower the Scientific Community With Publication Data Newswire
16-Jul-2024 Analysis Finds Misinformation About Interchangeable Biosimilars Undermining US Health Policy, Physician Confidence, and Patient Health Newswire
16-Jul-2024 Elixirgen Scientific Launches Advanced hiPSC-Derived Disease Panel for Alzheimer’s Disease Newswire
16-Jul-2024 Lab Awards to reunite the lab community in celebration Lab Innovations
15-Jul-2024 B2B Pharmacy Services Now Available from Canada Pharmacy Newswire
15-Jul-2024 iiCON has bolstered its team by making a senior appointment to establish the Category 3 AI Robotics Laboratory. The Infection Innovation Consortium
12-Jul-2024 CCDC Scientist Awarded Prestigious BACG Young Scientists Award CCDC
11-Jul-2024 Eurofins Acquires Leading UK Healthcare Water Testing Laboratory Eurofins Food & Water Testing UK
11-Jul-2024 Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market Cosette Pharmaceuticals
11-Jul-2024 Type 2 diabetes now one of the top five most studied diseases globally, finds new Phesi analysis Phesi
11-Jul-2024 New data shows UK life sciences failing to reach its potential Association of the British Pharmaceutical Industry (ABPI)
11-Jul-2024 AcceleDev Chemical LLC Unveils New 5,000-Sq.-Ft. R&D/GMP Production Site in Cranbury, New Jersey, USA Newswire
11-Jul-2024 Leading the Future of Nutrition: Mission Hill Foods' Innovations in Scientific Research and Sustainability Newswire
09-Jul-2024 New Canine Study From Belhaven Biopharma Supports Dry Powder Nasal Epinephrine Delivery Solution Newswire
09-Jul-2024 Roche receives CE Mark for its AI-enabled continuous glucose monitoring solution offering critical predictions to people living with diabetes Roche
09-Jul-2024 Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development Myricx Bio
09-Jul-2024 Syncona portfolio company Spur provides update on FLT201 and planned Phase III clinical trial Syncona LimitedSyncona Limited
09-Jul-2024 Pascal Piedbois, MD, PhD joins One2Treat as Chief Medical Officer to advance patient-centric innovation in clinical trial design and market access One2Treat
08-Jul-2024 Scailyte Strengthens Its Leadership Newswire